What is the Gnrh agonist?
Gnrh agonist or or gonadotropin relaxing hormones is a class of drugs used to control some hormones naturally excreted in the body. The hormones affected by GNRH agonists are usually those related to puberty and reproduction. Medicines in this class can be used to treat various conditions, including endometriosis, premature puberty and prostate cancer. Healthcare providers often warn against a number of possible and sometimes serious side effects and recommend the use of GNRH agonists in some people. Drugs in this class usually work by forcing the pituitary gland to first overproduction follicles stimulating hormone (FSH) and luteinizing hormone (LH), which play a role in the production of estrogen and testosterone of the body. Over time, this will cause the pituitary gland of FSH and LH, which leads to a reduction in the levels of these hormones, as well as estrogen and testosterone in the body.
as a result of this mechanismThe effect may be used by GNRH agonist in the treatment of certain conditions related to hormonal levels. In women, such conditions may include fibroids and endometriosis. These are both states related to the growth of tissue in the uterus, which is often stimulated by the presence of estrogen. By reducing the amount of estrogen circulating in the female body, the GnRH agonist can help prevent the abnormal tissue growth that is associated with these conditions, helping to relieve symptoms.
GNRH agonist can also be used in men and women to treat premature puberty, a condition that results in the pituitary of the pituitary hormones too early. By slowing down or closing the production of these hormones, the GNRH agonist can help delay the full progression of puberty. In adult men with advanced prostate cancer, GNRH agonist can also be used to reduce testosterone levels, which may be beneficial in stopping or slowing the growth of abnormal prostate tissue.
healthcare providers often warnPatients about various side effects associated with the use of GNRH agonist. Since drugs in this class first excessively stimulate hormone production, people may experience deteriorating symptoms at the beginning of treatment. Such symptoms may include increased pain and bleeding in women with endometriosis and increased urine symptoms in men with prostate cancer. These side effects are often often reflected after the initial period as the hormone levels begin to decrease.
Longer side effects may include loss of sexual desire, beats of beats and bone loss. Some studies have shown that men with prostate cancer who are treated with GNRH agonist may be for some at higher risk of Serita side effects such as heart attack, diabetes and stroke. Due to their effects on hormones and reproductive system, GNRH agonists are generally contraindicated in women who are breastfeeding, pregnant or trying to conceive.